Related Experiment Video

Updated: Jun 10, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide

Lars Christian Rump1, Lorenz Sellin

  • 1Department of Internal Medicine/Nephrology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany. christian.rump@med.uni-duesseldorf.de

Expert Opinion on Pharmacotherapy
|August 17, 2010
PubMed

Insights

Combining olmesartan medoxomil with hydrochlorothiazide (HCTZ) effectively lowers blood pressure (BP) in hypertensive patients. This combination therapy, including high-dose olmesartan, offers a safe and effective option for achieving BP goals when monotherapy fails.

Area of Science:

  • Cardiovascular medicine
  • Hypertension management
  • Pharmacotherapy

Background:

  • Cardiovascular disease is a leading cause of global mortality.
  • Effective blood pressure (BP) control is essential for reducing cardiovascular risk in hypertensive patients.
  • Many patients do not achieve target BP goals with current treatments.

Purpose of the Study:

  • To evaluate the efficacy and safety of combination therapy with olmesartan medoxomil and hydrochlorothiazide (HCTZ).
  • To assess the benefits of high-dose olmesartan in achieving target BP.
  • To provide an effective treatment option for patients with uncontrolled hypertension.

Main Methods:

  • Review of clinical trials assessing olmesartan medoxomil and HCTZ combination therapy.
  • Evaluation of antihypertensive efficacy and tolerability profiles.
  • Analysis of data from US and European 'treat-to-target' trials.

Main Results:

  • Combination therapy with olmesartan medoxomil and HCTZ demonstrates superior antihypertensive efficacy compared to monotherapy.
  • Higher doses of olmesartan may extend the duration of BP lowering.
  • The combination therapy showed a similar tolerability profile to monotherapy.

Conclusions:

  • Combination therapy with olmesartan (up to 40 mg) plus HCTZ is a safe and effective strategy for managing mild-to-severe hypertension.
  • This approach is particularly beneficial for patients who do not reach BP goals with monotherapy.
  • Optimized pharmacotherapy is crucial for achieving guideline-recommended BP targets.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...